# Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab

> **NCT00776763** · PHASE2 · COMPLETED · sponsor: **Ophthalmological Association Edelweiss** · enrollment: 150 (estimated)

## Conditions studied

- Proliferative Diabetic Retinopathy
- Age Related Macular Degeneration

## Interventions

- **DRUG:** Avastin intravitreal injection

## Key facts

- **NCT ID:** NCT00776763
- **Lead sponsor:** Ophthalmological Association Edelweiss
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-10
- **Final completion:** 2010-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2011-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00776763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00776763, "Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00776763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*